Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

COVID-19

Free Subscription Articles published in Zhonghua Jie He He Hu Xi Za Zhi Retrieve available abstracts of 49 articles: HTML format

Single Articles

October 2025
1. WANG MC, Liu X, Hu K
   [Intermittent hypoxia exposure in the rehabilitation of long COVID patients].
   Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:961-964.
   PubMed     Abstract available
   
   
   August 2025
2. MA N, Zhou BJ, Zhang JY, Gao J, et al
   [Clinical analysis of thirteen cases of pulmonary infection caused by Nocardia otitidiscaviarum].
   Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:732-737.
   PubMed     Abstract available
   
   
   June 2025
3. CHEN T, Xu ZJ
   [Recomment of the correctly understand and standardize the use of terms and concepts related to interstitial lung disease].
   Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:589-591.
   PubMed     Abstract available
   
   
   March 2025
4. ZHENG YJ, Hou JY, Zhong J, Ye XW, et al
   [A case of COVID-19-associated pulmonary aspergillosis combined with COVID-19-associated pulmonary mucormycosis].
   Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:267-271.
   PubMed     Abstract available
   
   
   February 2025
5. WANG T, Chen X, Shi XP, He YX, et al
   [COVID-19 infection with tracheobronchomalacia: a case report].
   Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:138-141.
   PubMed     Abstract available
   
   
   January 2025
6. SONG LC, Xie LX
   [Clinical update in critical care of pulmonary medicine 2024].
   Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:84-89.
   PubMed     Abstract available
   
   
   
7. LI SN, Ni WT, Li R, Chen YW, et al
   [Clinical characteristics of immunocompromised patients infected with COVID-19].
   Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:35-42.
   PubMed     Abstract available
   
   
   
8. 
   [Chinese expert consensus on the diagnosis and treatment of pneumonia in the elderly (2024 Edition)].
   Zhonghua Jie He He Hu Xi Za Zhi. 2025;48:18-34.
   PubMed     Abstract available
   
   
   November 2024
9. LIANG SF, Li WM, Liu D
   [Progress and challenges in clinical diagnosis and treatment of co-existent lung cancer and pulmonary tuberculosis].
   Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:1035-1041.
   PubMed     Abstract available
   
   
   September 2024
10. YU JP, Shang CC, Li H, Lyu C, et al
    [Research progress on T-cell immunity in patients infected with SARS-CoV-2].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:863-868.
    PubMed     Abstract available
    
    
    
11. MO HH, Huang H, Luo J, Liu LH, et al
    [Goods syndrome in chronic active SARS-CoV-2 infection: a case report].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:834-838.
    PubMed     Abstract available
    
    
    June 2024
12. HE LX
    [Pay attention to new evolution trends in the etiology of community-acquired pneumonia in adults].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:576-581.
    PubMed     Abstract available
    
    
    
13. ZHANG Z, Zhou M
    [COVID-19 and autoimmune dysregulation: exploring common mechanisms and treatment strategies in interstitial lung disease].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:571-575.
    PubMed     Abstract available
    
    
    May 2024
14. GU SJ, Wen JL, Wang XY, Zhang LX, et al
    [Progress in the diagnose and treatment of pulmonary arterial thrombosis in situ].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:464-469.
    PubMed     Abstract available
    
    
    
15. LIU MH, Sun YX, Li ZL, Zhang LJ, et al
    [Retrospective analysis of diagnosis and treatment of tuberculosis in designated medical institutions in China from 2017 to 2022].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:437-443.
    PubMed     Abstract available
    
    
    
16. YANG LL, Huang LT, Ren SY, Ouyang RY, et al
    [COVID-19 in patients with Good syndrome: report of 4 cases and literature review].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:430-436.
    PubMed     Abstract available
    
    
    April 2024
17. SUN ZZ, Sun GF, Zhuang R, Zhu LQ, et al
    [Best evidence summary for awake prone positioning in treating hypoxemic due to COVID-19 infection].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:313-318.
    PubMed     Abstract available
    
    
    March 2024
18. GAO HB, Zhang J
    [Analysis of prognostic factors in patients with COVID-19 infection].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:296-300.
    PubMed     Abstract available
    
    
    
19. GUO JW, Xiao Y
    [Impact of COVID-19 on the treatment of sleep medicine].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:292-296.
    PubMed     Abstract available
    
    
    
20. YU D, Huang WQ, Zhan YZ, Xiao GH, et al
    [Diaphragmatic dysfunction post-COVID-19 infection: report of two cases].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:244-248.
    PubMed     Abstract available
    
    
    
21. CHEN RX, Mai YL, Shen KN, Zhang T, et al
    [A case of follicular lymphoma with recurrent fever and pulmonary infiltrates].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:222-227.
    PubMed     Abstract available
    
    
    February 2024
22. ZHA SS, He ZF, Guan LL, Niu JY, et al
    [Clinical research progress in non-invasive positive pressure ventilation in 2023].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:146-151.
    PubMed     Abstract available
    
    
    
23. SHI YJ, Chen RX, Liu XN, Shao C, et al
    [Clinical analysis of COVID-19 in patients with preexisting interstitial lung abnormalities].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:126-131.
    PubMed     Abstract available
    
    
    December 2023
24. WANG SY, Wang YM, Liu M, Zhao L, et al
    [Migratory pulmonary ground glass opacities caused by SARS-CoV-2 infection in a patient on B-cell depletion therapy].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:1233-1239.
    PubMed     Abstract available
    
    
    
25. 
    [Expert consensus on the management of interstitial lung disease during the COVID-19 epidemic].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:1204-1218.
    PubMed     Abstract available
    
    
    
26. 
    [Expert consensus on diagnosis and treatment of severe COVID-19 associated with pulmonary aspergillus and mucormycosis].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;47:10-23.
    PubMed     Abstract available
    
    
    November 2023
27. HAN L, Sun LX, Chen YL, Shao HJ, et al
    [Clinical characteristics of a case of severe pneumonia caused by coinfection of COVID-19 and Chlamydia Psittaci].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:1118-1120.
    PubMed     Abstract available
    
    
    September 2023
28. 
    [Expert consensus on the diagnosis and management of Birt-Hogg-Dube syndrome].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:897-908.
    PubMed     Abstract available
    
    
    August 2023
29. HUANG LX, Liang YD, Wang YQ, Li JT, et al
    [Hemophagocytic syndrome secondary to COVID-19: a case report and literature review].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:791-796.
    PubMed     Abstract available
    
    
    May 2023
30. HUANG H
    [Comments on the systemic corticosteroid strategy for the coronavirus disease 2019 (COVID-19)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:521-524.
    PubMed     Abstract available
    
    
    
31. CHENG LL, Li SY, Zhong NS
    [New characteristics of COVID-19 caused by the Omicron variant in Guangzhou].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:441-443.
    PubMed     Abstract available
    
    
    April 2023
32. SU Y, Cao Y, Wang RL, Dong EJ, et al
    [Progress on specific and non-specific immune effects of Bacille Calmette-Guerin].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:413-418.
    PubMed     Abstract available
    
    
    February 2023
33. 
    [Expert consensus on off-label administration of drugs in COVID-19].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:1-10.
    PubMed     Abstract available
    
    
    
34. 
    [Thromboprophylaxis and management of anticoagulation in hospitalized patients with COVID-19: clinical pathway and practices].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:1-16.
    PubMed     Abstract available
    
    
    
35. TONG ZH, Jiang HY, Chen YS
    [Annual progress in pulmonary rehabilitation 2022].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:172-176.
    PubMed     Abstract available
    
    
    
36. YANG QY, Qu JM
    [Annual update of pulmonary infectious diseases in 2022].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:168-171.
    PubMed     Abstract available
    
    
    January 2023
37. 
    [Expert consensus on the diagnosis and treatment of SARS-CoV-2-associated cough].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:E002.
    PubMed     Abstract available
    
    
    
38. ZHA SS, He ZF, Guan LL, Niu JY, et al
    [Clinical update in non-invasive positive pressure ventilation for respiratory failure in 2022].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:77-81.
    PubMed     Abstract available
    
    
    
39. PAN P, Xie LX
    [Clinical update in critical care of pulmonary medicine 2022].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:72-76.
    PubMed     Abstract available
    
    
    
40. 
    [Expert consensus on treatment of severe COVID-19 caused by Omicron variants].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:E001.
    PubMed     Abstract available
    
    
    December 2022
41. LI Y, Liu SY, Zheng JP
    [Chest imaging-based artificial intelligence in the diagnosis of coronavirus disease 2019 and prospects for future research].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:1255-1260.
    PubMed     Abstract available
    
    
    
42. SHANG FQ, Chen H, Yang X, Wu MJ, et al
    [Clinical characteristics of patients infected with 2019-nCoV Omicron variants BA.2 and BA.5 in Xi'an city, China].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:1199-1203.
    PubMed     Abstract available
    
    
    August 2022
43. LONG QY, Zheng YL, Gao Z
    [Advances in SARS-CoV-2 diagnostic strategies during the later COVID-19 era].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:819-825.
    PubMed     Abstract available
    
    
    July 2022
44. CAI YQ, Zeng HQ, Li YP, Li NS, et al
    [Advances in clinical prediction scores for prognosis of coronavirus disease-2019].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:706-711.
    PubMed     Abstract available
    
    
    June 2022
45. LIU J, Wu JL, Liu GC, Jiang P, et al
    [Research progress on physiological changes caused by wearing N95 mask in patients with chronic obstruction pulmonary disease].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:598-602.
    PubMed     Abstract available
    
    
    
46. XU FY, Zhai ZG
    [Annual review of venous thromboembolism in 2021].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:588-592.
    PubMed     Abstract available
    
    
    May 2022
47. TENG PK, Han XD, Liu YZ, Zhao WY, et al
    [Clinical characteristics and outcome analysis of COVID-19 patients with pulmonary tuberculosis].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:510-514.
    PubMed     Abstract available
    
    
    April 2022
48. 
    [Chinese expert consensus on the use of Omalizumab in allergic asthma (2021 version)].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:341-354.
    PubMed     Abstract available
    
    
    
49. SUN YC
    [Focus on influenza vaccination in patients with chronic obstructive pulmonary disease].
    Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:333-334.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge.